6-K
File 001-15170
GSK RSV VACCINE FOR OLDER ADULTS APPROVED IN JAPAN
- Filing date
- 25 Sep 2023
- Reporting date
- 25 Sep 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
GSK plc reports
- Company location
- London
GSK plc has filed 6,818 SEC EDGAR filings since 12 Jan 2001
SEC filing history
Showing 776-800 of 1,000 matching filings.
Per page
25
Current page
32
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 21 Sep 2023
- Reporting date
- 21 Aug 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
APRETUDE FOR PREP RECEIVES EMA APPROVAL
- Filing date
- 19 Sep 2023
- Reporting date
- 19 Sep 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
FDA APPROVES OJJAARA (MOMELOTINIB)
- Filing date
- 18 Sep 2023
- Reporting date
- 18 Sep 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 13 Sep 2023
- Reporting date
- 13 Sep 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SC 13D/A
AMENDMENT TO FORM SC 13D
- Filing date
- 11 Sep 2023
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 11 Sep 2023
- Reporting date
- 11 Sep 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
MOMELOTINIB FILING ACCEPTED IN JAPAN
- Filing date
- 11 Sep 2023
- Reporting date
- 11 Sep 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 06 Sep 2023
- Reporting date
- 06 Sep 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TOTAL VOTING RIGHTS
- Filing date
- 01 Sep 2023
- Reporting date
- 01 Sep 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
GSK'S NUCALA CRSWNP SUBMISSION ACCEPTED IN JAPAN
- Filing date
- 01 Sep 2023
- Reporting date
- 01 Sep 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
HOLDING(S) IN COMPANY
- Filing date
- 31 Aug 2023
- Reporting date
- 31 Aug 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
HOLDING(S) IN COMPANY
- Filing date
- 31 Aug 2023
- Reporting date
- 31 Aug 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 25 Aug 2023
- Reporting date
- 25 Aug 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 23 Aug 2023
- Reporting date
- 23 Aug 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
SHINGRIX DATA DEMONSTRATE 100% EFFICACY IN CHINA
- Filing date
- 23 Aug 2023
- Reporting date
- 23 Aug 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 22 Aug 2023
- Reporting date
- 22 Aug 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 10 Aug 2023
- Reporting date
- 10 Aug 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 09 Aug 2023
- Reporting date
- 09 Aug 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TOTAL VOTING RIGHTS
- Filing date
- 01 Aug 2023
- Reporting date
- 01 Aug 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
FDA APPROVES NEW USE FOR JEMPERLI PLUS CHEMO
- Filing date
- 31 Jul 2023
- Reporting date
- 31 Jul 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 31 Jul 2023
- Reporting date
- 31 Jul 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 28 Jul 2023
- Reporting date
- 28 Jul 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
2ND QUARTER RESULTS
- Filing date
- 26 Jul 2023
- Reporting date
- 26 Jul 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
CABOTEGRAVIR LA FOR PREP RECEIVES POSITIVE CHMP
- Filing date
- 24 Jul 2023
- Reporting date
- 24 Jul 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing